Pharma News

Janssen Research & Development, LLC announced it has entered into a clinical trial collaboration agreement with Genentech, a member of the Roche Group, to initiate two studies to determine the safety and tolerability of daratumumab (DARZALEX®), the first CD38-directed monoclonal antibody (mAb), in combination with atezolizumab, an investigational mAb designed to bind with a protein called programmed cell death-ligand 1 (PD-L1).

Teva Pharmaceutical Industries Ltd., announced the launch of the generic equivalent to CAMPRAL®1 (acamprosate calcium) delayed-release tablets, 333 mg, in the United States. Acamprosate calcium delayed-release tablets are used for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at the start of treatment.

Spending on programmes to control India’s three main communicable diseases malaria, tuberculosis and leprosy increased seven percent over five years while cases reported, taken together, increased 32 percent, according to an IndiaSpend analysis of government data.

[adsense:336x280:8701650588]

Malaria, a life-threatening disease caused by parasites that are transmitted to people through mosquitoe bites, started out as a parasite in birds, and then it evolved to colonise bats, and from there it has evolved to affect other mammals, reveals a new study.

The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.

Administration of three or more courses of antibiotics before a child reaches the age of two is linked to increased risk of early childhood obesity, says a new study.

With the government announcing eradication of tuberculosis by 2030, a doctor has says a new 'Endobroncial Ultrasound' medical process that was introduced in India recently can contribute in faster diagnosis of the disease leading to correct treatment on time.